Self-Affirmation for Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a writing exercise called self-affirmation to determine if it helps people with type 2 diabetes feel less stigma and improve diabetes management. Participants will write about their personal values before wellness appointments to boost motivation and control over their condition. Researchers will compare these effects to a control group completing shorter writing tasks. The trial seeks individuals diagnosed with type 2 diabetes who regularly use a continuous glucose monitor and are patients at MaineHealth Endocrinology and Diabetes. As an unphased trial, this study offers a unique opportunity to explore innovative ways to enhance diabetes management and personal well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on self-affirmation exercises and does not mention changes to medication.
What prior data suggests that this self-affirmation intervention is safe for individuals with diabetes?
Research has shown that self-affirmation techniques are generally safe. Studies have found that these exercises can lead to positive outcomes, particularly in health settings. For instance, practicing self-affirmation often makes individuals more receptive to health advice and better at managing stress, which can be especially beneficial for those with diabetes.
No reports of harmful effects from self-affirmation exercises exist. These exercises involve writing about personal values and how they assist in difficult situations. This simple process does not involve medical procedures or drugs, reducing the risk of side effects.
Overall, self-affirmation is considered well-tolerated. It offers a safe way to potentially enhance well-being and assist in managing diabetes.12345Why are researchers excited about this trial?
Researchers are excited about self-affirmation as a new approach for managing diabetes because it focuses on psychological empowerment rather than traditional medical interventions like insulin or oral medications. This technique encourages individuals to reflect on their personal values, which may help them cope with the stress and challenges of managing diabetes. By broadening their focus beyond the condition itself, self-affirmation has the potential to improve mental resilience and overall well-being, which could complement existing treatments and enhance their effectiveness.
What evidence suggests that self-affirmation might be an effective treatment for diabetes?
Studies have shown that self-affirmation exercises, which participants in this trial may receive, can improve the well-being of people with diabetes. Research indicates that these exercises increase motivation and interest in managing diabetes. They help individuals focus on what is important to them, reducing stress and boosting confidence. Initial findings suggest that self-affirmation can lessen feelings of shame and enhance body image in people with diabetes. Overall, this approach has the potential to make managing diabetes easier and more positive.26789
Who Is on the Research Team?
Elizabeth Scharnetzki
Principal Investigator
MaineHealth
Are You a Good Fit for This Trial?
This trial is for adults with type 2 diabetes who are already using a continuous glucose monitor. It's designed to see if self-affirmation exercises before doctor visits can help manage the emotional and psychological challenges of living with diabetes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants complete self-affirmation writing exercises before their 3-month wellness appointments
Follow-up
Participants are monitored for changes in stigma, self-efficacy, and glucose control
What Are the Treatments Tested in This Trial?
Interventions
- Self-Affirmation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Elizabeth Scharnetzki
Lead Sponsor
MaineHealth Institute for Research
Collaborator
MaineHealth
Collaborator